These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20584172)

  • 1. Relationship of sFas with metabolic risk factors and their clusters.
    Tamakoshi A; Suzuki K; Lin Y; Ito Y; Yagyu K; Kikuchi S; Watanabe Y; Inaba Y; Tajima K; Nakachi K;
    Eur J Clin Invest; 2010 Jun; 40(6):527-33. PubMed ID: 20584172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST.
    Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Hérnandez G; Egido J;
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):168-74. PubMed ID: 17053166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
    Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F
    Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and serum soluble Fas levels: Findings from the JACC study.
    Tamakoshi A; Suzuki K; Lin Y; Ito Y; Yagyu K; Kikuchi S; Watanabe Y; Inaba Y; Tajima K; Nakachi K;
    Mutat Res; 2009; 679(1-2):79-83. PubMed ID: 19682600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-soluble Fas levels are increased in type 2 diabetic patients with peripheral vascular disease.
    García-Unzueta MT; Pesquera C; Calzada E; De la Mora A; Muñoz P; Llorca J; Morchón N; Fernández-González MD; Amado JA
    Horm Metab Res; 2006 Oct; 38(10):673-7. PubMed ID: 17075777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
    Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
    Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
    Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
    Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
    Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T; Toi M; Tominaga T
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population.
    Tanyolaç S; Sertkaya Cikim A; Doğan Azezli A; Orhan Y
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):336-41. PubMed ID: 18849223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
    Ugurel S; Rappl G; Tilgen W; Reinhold U
    Clin Cancer Res; 2001 May; 7(5):1282-6. PubMed ID: 11350895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
    Konno R; Takano T; Sato S; Yajima A
    Clin Cancer Res; 2000 Sep; 6(9):3576-80. PubMed ID: 10999747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse.
    van Lopik T; Bijl M; Hart M; Boeije L; Gesner T; Creasy AA; Kallenberg CG; Aarden LA; Smeenk RJ
    J Rheumatol; 1999 Jan; 26(1):60-7. PubMed ID: 9918241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.